Our Team

The core 3E team has more than 10 years of healthcare investment experience and industry expertise in pharmaceutical and biotech.

Join Us
← View Team

Melford Yuan

Melford Yuan joined 3E Bioventures in March 2021 as a partner of the fund.  Mr. Yuan started his career in 1994, He has worked in UBS, DLJ/CSFB,TD Securities and ABN AMRO bank till 2003. Joined Deutsche Bank in 2003 and became co-head of DCM China. Helped various Chinese companies to raise fund overseas over USD 10bn. In 2007, Melford joined Morgan Stanley Asia. He worked in Morgan Stanley as managing director in Global Capital Markets and Investment Banking Division. During his time in Morgan Stanley, he has engaged in many areas of debt/equity financing and M&A for mainly Chinese companies. Since left Morgan Stanley at then end of 2014, Melford worked as an advisor to CEO of Beijing Enterprises Holding till beginning of 2018. At the meantime, Melford Yuan serves as a senior advisor to Blackstone Group from 2016. 

Mr. Yuan studied law in Capital University of Business and Economics, and Economics in  State University of New York. He is fluent in Mandarin, English and Japanese.